Germline splicing mutations of CDKN2A predispose to melanoma

Joanne C Y Loo, Ling Liu, AiHua Hao, LuZhuang Gao, Ron Agatep, Michael Shennan, Anne Summers, Alisa M. Goldstein, Margaret A. Tucker, Carolyn Deters, Ramon Fusaro, Kathleen Blazer, Jeffrey Weitzel, Norman Lassam, Henry T. Lynch, David Hogg

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Coding mutations of the CDKN2A gene on chromosome 9p21 cosegregate with 25-60% of familial melanoma cases, but there remains a number of 9p21-linked kindreds that lack germline coding mutations of CDKN2A. We sequenced CDKN2A exons 1α, 2, 3, and the adjacent intronic regions in 167 melanoma-prone families (at least two affected first-degree relatives), and detected four splice site variations, three of which cosegregate with the disease. RT-PCR experiments verified that these three variants, including an AGgt to ATgt mutation that demonstrates a founder effect, do affect splicing. While an exon 1α splice donor site mutation incompletely abolishes splicing, the correctly spliced mRNA yields a protein (Q50P) that cannot effectively interact with CDK4. We also performed RT-PCR on mRNA from 16 melanoma-prone kindreds to search for cryptic splice sites deep within introns, but identified no splice variants. Meanwhile, we screened 139 affected families using allelespecific PCR for the recently discovered IVS2-105A > G mutation, but found only one family that possesses this alteration. We conclude that splice site mutations do predispose to disease in a subset of melanoma-prone kindreds. Characterization of additional splice site variants and other noncoding alterations of CDKN2A should allow us to detect a wider range of mutations in atrisk patients.

Original languageEnglish
Pages (from-to)6387-6394
Number of pages8
JournalOncogene
Volume22
Issue number41
DOIs
StatePublished - Sep 25 2003

Fingerprint

Germ-Line Mutation
Melanoma
Mutation
RNA Splice Sites
Polymerase Chain Reaction
Exons
p16 Genes
Founder Effect
Messenger RNA
Introns
Chromosomes
Proteins

All Science Journal Classification (ASJC) codes

  • Molecular Biology
  • Cancer Research
  • Genetics

Cite this

Loo, J. C. Y., Liu, L., Hao, A., Gao, L., Agatep, R., Shennan, M., ... Hogg, D. (2003). Germline splicing mutations of CDKN2A predispose to melanoma. Oncogene, 22(41), 6387-6394. https://doi.org/10.1038/sj.onc.1206736

Germline splicing mutations of CDKN2A predispose to melanoma. / Loo, Joanne C Y; Liu, Ling; Hao, AiHua; Gao, LuZhuang; Agatep, Ron; Shennan, Michael; Summers, Anne; Goldstein, Alisa M.; Tucker, Margaret A.; Deters, Carolyn; Fusaro, Ramon; Blazer, Kathleen; Weitzel, Jeffrey; Lassam, Norman; Lynch, Henry T.; Hogg, David.

In: Oncogene, Vol. 22, No. 41, 25.09.2003, p. 6387-6394.

Research output: Contribution to journalArticle

Loo, JCY, Liu, L, Hao, A, Gao, L, Agatep, R, Shennan, M, Summers, A, Goldstein, AM, Tucker, MA, Deters, C, Fusaro, R, Blazer, K, Weitzel, J, Lassam, N, Lynch, HT & Hogg, D 2003, 'Germline splicing mutations of CDKN2A predispose to melanoma', Oncogene, vol. 22, no. 41, pp. 6387-6394. https://doi.org/10.1038/sj.onc.1206736
Loo JCY, Liu L, Hao A, Gao L, Agatep R, Shennan M et al. Germline splicing mutations of CDKN2A predispose to melanoma. Oncogene. 2003 Sep 25;22(41):6387-6394. https://doi.org/10.1038/sj.onc.1206736
Loo, Joanne C Y ; Liu, Ling ; Hao, AiHua ; Gao, LuZhuang ; Agatep, Ron ; Shennan, Michael ; Summers, Anne ; Goldstein, Alisa M. ; Tucker, Margaret A. ; Deters, Carolyn ; Fusaro, Ramon ; Blazer, Kathleen ; Weitzel, Jeffrey ; Lassam, Norman ; Lynch, Henry T. ; Hogg, David. / Germline splicing mutations of CDKN2A predispose to melanoma. In: Oncogene. 2003 ; Vol. 22, No. 41. pp. 6387-6394.
@article{df9b468ab11d4670858d2d19a1cd2119,
title = "Germline splicing mutations of CDKN2A predispose to melanoma",
abstract = "Coding mutations of the CDKN2A gene on chromosome 9p21 cosegregate with 25-60{\%} of familial melanoma cases, but there remains a number of 9p21-linked kindreds that lack germline coding mutations of CDKN2A. We sequenced CDKN2A exons 1α, 2, 3, and the adjacent intronic regions in 167 melanoma-prone families (at least two affected first-degree relatives), and detected four splice site variations, three of which cosegregate with the disease. RT-PCR experiments verified that these three variants, including an AGgt to ATgt mutation that demonstrates a founder effect, do affect splicing. While an exon 1α splice donor site mutation incompletely abolishes splicing, the correctly spliced mRNA yields a protein (Q50P) that cannot effectively interact with CDK4. We also performed RT-PCR on mRNA from 16 melanoma-prone kindreds to search for cryptic splice sites deep within introns, but identified no splice variants. Meanwhile, we screened 139 affected families using allelespecific PCR for the recently discovered IVS2-105A > G mutation, but found only one family that possesses this alteration. We conclude that splice site mutations do predispose to disease in a subset of melanoma-prone kindreds. Characterization of additional splice site variants and other noncoding alterations of CDKN2A should allow us to detect a wider range of mutations in atrisk patients.",
author = "Loo, {Joanne C Y} and Ling Liu and AiHua Hao and LuZhuang Gao and Ron Agatep and Michael Shennan and Anne Summers and Goldstein, {Alisa M.} and Tucker, {Margaret A.} and Carolyn Deters and Ramon Fusaro and Kathleen Blazer and Jeffrey Weitzel and Norman Lassam and Lynch, {Henry T.} and David Hogg",
year = "2003",
month = "9",
day = "25",
doi = "10.1038/sj.onc.1206736",
language = "English",
volume = "22",
pages = "6387--6394",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "41",

}

TY - JOUR

T1 - Germline splicing mutations of CDKN2A predispose to melanoma

AU - Loo, Joanne C Y

AU - Liu, Ling

AU - Hao, AiHua

AU - Gao, LuZhuang

AU - Agatep, Ron

AU - Shennan, Michael

AU - Summers, Anne

AU - Goldstein, Alisa M.

AU - Tucker, Margaret A.

AU - Deters, Carolyn

AU - Fusaro, Ramon

AU - Blazer, Kathleen

AU - Weitzel, Jeffrey

AU - Lassam, Norman

AU - Lynch, Henry T.

AU - Hogg, David

PY - 2003/9/25

Y1 - 2003/9/25

N2 - Coding mutations of the CDKN2A gene on chromosome 9p21 cosegregate with 25-60% of familial melanoma cases, but there remains a number of 9p21-linked kindreds that lack germline coding mutations of CDKN2A. We sequenced CDKN2A exons 1α, 2, 3, and the adjacent intronic regions in 167 melanoma-prone families (at least two affected first-degree relatives), and detected four splice site variations, three of which cosegregate with the disease. RT-PCR experiments verified that these three variants, including an AGgt to ATgt mutation that demonstrates a founder effect, do affect splicing. While an exon 1α splice donor site mutation incompletely abolishes splicing, the correctly spliced mRNA yields a protein (Q50P) that cannot effectively interact with CDK4. We also performed RT-PCR on mRNA from 16 melanoma-prone kindreds to search for cryptic splice sites deep within introns, but identified no splice variants. Meanwhile, we screened 139 affected families using allelespecific PCR for the recently discovered IVS2-105A > G mutation, but found only one family that possesses this alteration. We conclude that splice site mutations do predispose to disease in a subset of melanoma-prone kindreds. Characterization of additional splice site variants and other noncoding alterations of CDKN2A should allow us to detect a wider range of mutations in atrisk patients.

AB - Coding mutations of the CDKN2A gene on chromosome 9p21 cosegregate with 25-60% of familial melanoma cases, but there remains a number of 9p21-linked kindreds that lack germline coding mutations of CDKN2A. We sequenced CDKN2A exons 1α, 2, 3, and the adjacent intronic regions in 167 melanoma-prone families (at least two affected first-degree relatives), and detected four splice site variations, three of which cosegregate with the disease. RT-PCR experiments verified that these three variants, including an AGgt to ATgt mutation that demonstrates a founder effect, do affect splicing. While an exon 1α splice donor site mutation incompletely abolishes splicing, the correctly spliced mRNA yields a protein (Q50P) that cannot effectively interact with CDK4. We also performed RT-PCR on mRNA from 16 melanoma-prone kindreds to search for cryptic splice sites deep within introns, but identified no splice variants. Meanwhile, we screened 139 affected families using allelespecific PCR for the recently discovered IVS2-105A > G mutation, but found only one family that possesses this alteration. We conclude that splice site mutations do predispose to disease in a subset of melanoma-prone kindreds. Characterization of additional splice site variants and other noncoding alterations of CDKN2A should allow us to detect a wider range of mutations in atrisk patients.

UR - http://www.scopus.com/inward/record.url?scp=0142072167&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0142072167&partnerID=8YFLogxK

U2 - 10.1038/sj.onc.1206736

DO - 10.1038/sj.onc.1206736

M3 - Article

VL - 22

SP - 6387

EP - 6394

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 41

ER -